Clinical Trial Update: A Dose-finding Study of ASP4070 [Phase 2]

View source ↗

Summary

This is a Phase 2 dose-finding study of ASP4070 for seasonal allergic rhinitis; results from the trial have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• ASP4070

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED | Results posted: 2020-06-30